Comparison of the Effects of Transdermal and Oral Rivastigmine on Cognitive Function and EEG Markers in Patients With Alzheimer’s Disease

Frontiers in Aging Neuroscience - Switzerland
doi 10.3389/fnagi.2014.00179
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search